ACE2 |
angiotensin-converting enzyme 2 |
APTT |
activated partial thromboplastin time |
ARDS |
acute respiratory distress syndrome |
AVDS |
acute vascular distress syndrome |
cGMP |
cyclic guanosine monophosphate |
COVID-19 |
coronavirus disease 2019 |
CT |
computed tomography |
CTEPH |
chronic thromboembolic pulmonary hypertension |
DECT |
contrast dual-energy CT |
DLCO |
diffusing capacity for carbon monoxide |
DVT |
deep vein thrombosis |
ECMO |
extracorporeal membrane oxygenation |
eNOS |
endothelial nitric oxide synthase |
EPCR |
thrombomodulin and endothelial cell protein C receptor |
EPO |
erythropoietin |
ERK |
extracellular signal-regulated kinase |
HbNO |
5-α-nitrosyl-hemoglobin |
HHV-8 |
human herpesvirus-8 |
HIF |
hypoxia-inducible factor |
HIV |
human immunodeficiency virus |
HPV |
hypoxic pulmonary vasoconstriction |
ICU |
intensive care unit |
IL |
interleukin |
INR |
international normalized ratio |
iNOS |
inducible NO synthase |
LA |
lupus anticoagulant |
MCP-1 |
monocyte chemoattractant protein 1 |
MEK |
mitogen-activated protein kinase |
NETs |
neutrophil extracellular traps |
NF-kB |
nuclear factor kappa beta |
NO |
nitric oxide |
OPN |
osteopontin |
PAI-1 |
plasminogen activator inhibitor-1 |
PAH |
pulmonary arterial hypertension |
PAMPs |
pathogen-associated molecular patterns |
PAP |
pulmonary arterial pressure |
PE |
pulmonary embolism |
PH |
pulmonary hypertension |
PVR |
pulmonary vascular resistance |
RAAS |
renin–angiotensin–aldosterone system |
RHC |
right heart catheterization |
ROS |
reactive oxygen species |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus 2 |
SPECT |
ventilation-perfusion single-photon emission computed tomography (SPECT) |
TF |
tissue factor |
TFPI |
tissue factor pathway inhibitor |
uPA |
urokinase plasminogen activator |
uPAR |
urokinase plasminogen activator receptor |
VEGF |
vascular endothelial growth factor |
VTE |
venous thromboembolic events |
vWF |
von Willebrand factor |